Member access

4-Traders Homepage  >  Shares  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CHF)
Sales 2015 46 685 M
EBIT 2015 16 618 M
Net income 2015 11 371 M
Debt 2015 8 635 M
Yield 2015 3,16%
Sales 2016 48 659 M
EBIT 2016 17 738 M
Net income 2016 12 408 M
Debt 2016 4 322 M
Yield 2016 3,33%
PER 2015 20,05
PER 2016 18,46
EV / Sales 2015 5,04x
EV / Sales 2016 4,75x
Capitalization 226 715 M
More Financials
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
04/02Shareholder meeting
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
03/22 Currency hedging takes on new importance for global stock funds
03/19 ROCHE : Sigma-Aldrich : Announces Exclusive Distribution Agreement with Roche
03/12DJ23andMe to Use Genetic Database for Drug Discovery
03/05DJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 4th Update
03/05DJAbbVie to Buy Pharmacyclics in $21 Billion Deal -- 3rd Update
03/05 ROCHE HOLDING LTD. : ex-dividend day for annual dividend
03/03 ROCHE : Global scientific collaborators to explore latest pathology and oncology..
02/25 Biosimilar copies of blockbuster drug launch in major EU markets
More news
Sector news : Pharmaceuticals - NEC
01:20p GRIFOLS : to make a major equity investment in Alkahest
12:10p GLAXOSMITHKLINE : Britain to offer all infants meningitis B vaccine
03/28 GLAXOSMITHKLINE : GSK statement on meningitis vaccination in the UK
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF